⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment that Promotes Metastasis and Immunotherapy Resistance

Xiaodong Shu Jianjie Li Un In Chan Sek Man Su Changxiang Shi Xin Zhang Tingting An Jun Xu Lihua Mo Jianlin Liu Yuqing Wang Xiaoling Li Min Deng Josh Haipeng Lei Chunfei Wang Hao Tian Heng Sun Joong Sup Shim Xuanjun Zhang Yunlu Dai Zhicheng Yao Xiaying Kuang Ying Lin Chu‐Xia Deng Xiaoling Xu

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

All supplementary tables in one excel file

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Shu et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db6435875231d1 https://doi.org/10.1158/0008-5472.27027949

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment that Promotes Metastasis and Immunotherapy Resistance2024
2Data from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment that Promotes Metastasis and Immunotherapy Resistance2024
3Supplementary Excel S6 from Dynamic glycoprotein hyposialylation promotes chemotherapy evasion and metastatic seeding of quiescent circulating tumor cell clusters in breast cancer2024
4Supplementary Excel S6 from Dynamic glycoprotein hyposialylation promotes chemotherapy evasion and metastatic seeding of quiescent circulating tumor cell clusters in breast cancer2024
5Supplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer2024

More related papers

Supplementary Data from Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer2024
Supplementary Figure S1 from Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma2024
Supplementary Figure S1 from Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma2024